Home/Novartis/Patrice Bula
PB

Patrice Bula

Lead Independent Director

Novartis

Novartis Pipeline

DrugIndicationPhase
Cosentyx®Pediatric Hidradenitis Suppurativa (12+)Approved
Pan-mutant-selective PI3Kα inhibitorBreast CancerAcquisition